Balchem Corporation BCPC · NASDAQ
$170.42 -0.18% (-$0.31)
Summary
78 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 15 USD is left as net profit.
- It has raised its dividend 16 years in a row and pays out only 19% of profit.
- Earnings per share grew by 13% a year over the last 3 years.
- It earns 12 USD a year on every 100 USD of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
- It missed profit estimates 4 times in the last 8 quarters.
- Revenue growth is slowing: 3.2% a year over the last 3 years against 8.1% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 33.1 USD for 1 USD of yearly profit. Over the last five years it was 42.6 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 8.1% a year over 5 years. Over the last 3 years it grew by 3.2% a year. Earnings per share grew by 13% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 64 USD
- Research and development 2.3 USD
- Sales and administration 13 USD
- Taxes and other 6.0 USD
- Net profit 15 USD
Net profit, industry median (Chemicals - Specialty) 6.0 USD
Out of every 100 USD of revenue, 15 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.56%
- Paid out of profit
- 19%
- Raised in a row
- 16 years
You receive $0.96 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 6
- Hold 4
- Sell 0
Today's price within the analysts' price targets
The average target of $215 is 26% above today's price. 60% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product Sales 100%
- Royalty 0.2%
By region
- UNITED STATES 73%
- Non-US 27%
Product Sales brings in 100% of revenue.
Segments in detail